Treatment with HSV-P10 in comparison to the non-PTEN expressing HSVQ in a panel of tumour cell lines showed a reduction in cell surface PD-L1 expression on tumour cells, thereby helping to overcome tumour immune escape [67]. This evidence concerns the gene CD274 and neoplasm.